SEPTInvestingStart Free
Stocks/IVF/SEC Filings/8-K Aug 28, 2026

IVF 8-K: Secondary offering

INVO Fertility

Filed with the SEC on Aug 28, 2026 · accession 0001493152-26-040504

IVF filed a 8-K (current report) with the SEC on Aug 28, 2026. INVO Fertility disclosed that it has sold 2,094,395 shares of common stock to Alumni Capital LP under its existing $15 million Any Market Purchase Agreement for approximately $3,591,000, at an average price of about $1.71 per share. The stock moved -2.9% by the first close after the filing.

Summary of the filing

INVO Fertility disclosed that it has sold 2,094,395 shares of common stock to Alumni Capital LP under its existing $15 million Any Market Purchase Agreement for approximately $3,591,000, at an average price of about $1.71 per share. The company also furnished an investor presentation for the H.C. Wainwright Global Investment Conference.

For details, click here →How to read a 8-K →

Key details

Aggregate commitment amount under Any Market Purchase Agreement$15.0M
Gross proceeds from shares sold to Alumni Capital LP$3.6M
Average price per share sold$2
IssuerINVO Fertility, Inc.
Investor/purchaser under any market purchase agreementAlumni Capital LP
Chief executive officerSteven Shum

How IVF stock reacted

Close before

$4.12

Aug 27, 2026

First close after

-2.91%

$4.00

5 trading days

-4.52%

$3.93

Since filing

-48.06%

$2.14

✦ Ask GOAX AI about this filing — what it means for IVF, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IVF?

Click here

Frequently asked questions

What did IVF file with the SEC on Aug 28, 2026?

IVF filed a 8-K (Secondary offering). INVO Fertility disclosed that it has sold 2,094,395 shares of common stock to Alumni Capital LP under its existing $15 million Any Market Purchase Agreement for approximately $3,591,000, at an average price of about $1.71 per share. The company also furnished an investor presentation for the H.C. Wainwright Global Investment Conference.

What does a secondary offering mean for IVF stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did IVF stock react to this filing?

IVF closed at $4.12 before the filing and $4.00 on Aug 28, 2026 (-2.91%). Five trading days later: $3.93 (-4.52%).

Other IVF SEC filings

  • 8-K · Stock splitNov 4, 2026
  • SCHEDULE 13G/A · SEC filingOct 9, 2026
  • 8-K · SEC filingAug 17, 2026
  • SCHEDULE 13G/A · SEC filingAug 14, 2026
  • 10-Q · SEC filingAug 14, 2026
  • 424B3 · Secondary offeringAug 7, 2026
  • S-1 · AcquisitionJul 24, 2026
  • 8-K · Material agreementJul 24, 2026
  • 8-K · AcquisitionJun 25, 2026
  • DEF 14A · Board changeJun 23, 2026

Get alerts when IVF files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
IVF overviewIVF analysisIVF newsLatest SEC filings
Source: SEC EDGAR filing 0001493152-26-040504. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.